| CHD3 antibodies | |
| This is a review about CHD3 antibodies, based on 5 published articles using CHD3 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited CHD3 antibody. Information in this review (with links to publications) can be searched freely. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology CHD3 products
includes other brands or spellings
|
| chip, wb | | Santa Cruz rabbit Mi2 (H-242) antibody was used in western blot and ChIP assay to study MTA1-mediated repression of 92-kDa type IV collagenase expression. |
| wb | | Santa Cruz Biotechnology goat polyclonal anti-Mi2 antibody was used in western blot to study the localization of two components of the NuRD complex, MBD3 and HDAC1 at aurora-A-positive centrosomes in M phase. |
| wb | | Santa Cruz Biotechnology anti-Mi-2 antibody was used in western blot to study the association of BRMS1 with RBP1 and the mSin3 histone deacetylase complex. |
BD BIOSCIENCES search BD Biosciences CHD3 products
includes other brands or spellings
|
| wb | | BD Transduction CHD3 antibody was tested in western blot by Abminer. |
MILLIPORE search Millipore CHD3 products
includes other brands or spellings
|
| wb | | Upstate Biotechnology anti-Mi2 antibody was used in western blot to study that MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing. |
Articles Reviewed |
| 1. Hirotaka Sakai et al. MBD3 and HDAC1, two components of the NuRD complex, are localized at Aurora-A-positive centrosomes in M phase. 2002 |
| 2. Chunhong Yan et al. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. 2003 |
| 3. William J Meehan et al. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. 2004 |
| 4. Seung-Gi Jin et al. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing. 2005 |
| 5. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |
|